ABSTRACT & COMMENTARY

New Guidelines on p16/Ki67 Dual Stain for Triage of HPV-Positive Cervical Cancer Screening Tests

May 1, 2024

This article outlines national consensus guidelines for the use of p16/Ki67 dual stain for triage of human papillomavirus-positive cervical cancer screening tests.

Issue Date: May 1, 2024

Table of Contents

Novel Combined Oral Contraceptives and VTE Risk: What Do We Know?
New Guidelines on p16/Ki67 Dual Stain for Triage of HPV-Positive Cervical Cancer Screening Tests
Medications for OUD in the First Trimester and Congenital Malformation Risk
Supplemental Calcium Therapy for the Prevention of Preeclampsia and Preterm Birth

Dr. Rebecca H. Allen (editor) reports that she is a consultant for Merck. The relevant financial relationship listed for this individual has been mitigated. None of the remaining planners or authors for this educational activity have relevant financial relationships to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Subscription Publication Books & Study Guides Group & Site Licenses State CME/CE Requirements